{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:01:43Z","timestamp":1758272503494},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1746-1596-9-116","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T18:01:57Z","timestamp":1402941717000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["KRAS, EGFR, PDGFR-\u03b1, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)"],"prefix":"10.1186","volume":"9","author":[{"given":"Lothar","family":"Veits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Schupfner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Penzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6ren","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Neuhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt W","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf J","family":"Rieker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,16]]},"reference":[{"key":"996_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/BF01656263","volume":"9","author":"A Miyauchi","year":"1985","unstructured":"Miyauchi A, Kuma K, Matsuzuka F, Matsubayashi S, Kobayashi A, Tamai H, Katayama S: Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid. World J Surg. 1985, 9: 128-135.","journal-title":"World J Surg"},{"key":"996_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0046-8177(91)90083-2","volume":"22","author":"JK Chan","year":"1991","unstructured":"Chan JK, Rosai J: Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol. 1991, 22: 349-367.","journal-title":"Hum Pathol"},{"key":"996_CR3","first-page":"96","volume-title":"World Health Organization Classification of Tumours. Tumours of Endocrine Organs","author":"W Cheuk","year":"2004","unstructured":"Cheuk W, Chan JKC, Dorfmann DM, Giordano T: Spindle Cell Tumour With Thymus-Like Differentiation. World Health Organization Classification of Tumours. Tumours of Endocrine Organs. Edited by: DeLellis RA, Lloyd RV, Heitz PU, Eng C. 2004, Lyon: IARC Press, 96-97."},{"key":"996_CR4","first-page":"151","volume-title":"Recent Advances in Thyroid Cancer Research","author":"Y Ito","year":"2006","unstructured":"Ito Y, Miyauchi A, Nakamura Y, Miya A, Kobayashi K, Kakudo K: Intrathyroid Epithelial Thymoma\/Carcinoma Showing Thymus-Like Differentiation (CASTLE): Its Clinicopathological Characteristics. Recent Advances in Thyroid Cancer Research. 2006, Kerala: Transworld Research Network, 151-164."},{"key":"996_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ajcp\/83.2.135","volume":"83","author":"ML Carcangiu","year":"1985","unstructured":"Carcangiu ML, Steeper T, Zampi G, Rosai J: Anaplastic thyroid carcinoma: a study of 70 cases. Am J Clin Pathol. 1985, 83: 135-158.","journal-title":"Am J Clin Pathol"},{"key":"996_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1746-1596-2-13","volume":"2","author":"BA Alexiev","year":"2007","unstructured":"Alexiev BA, Drachenberg CB, Burke AP: Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagn Pathol. 2007, 2: 13-","journal-title":"Diagn Pathol"},{"key":"996_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-011-1117-7","volume":"459","author":"L Veits","year":"2011","unstructured":"Veits L, Mechtersheimer G, Steger C, Freitag J, Mikuz G, Schmid KW, Hofmann W, Schirmacher P, Hartmann A, Rieker RJ: Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE). Virchows Arch. 2011, 459: 221-226.","journal-title":"Virchows Arch"},{"key":"996_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","volume":"130","author":"JD Henley","year":"2004","unstructured":"Henley JD, Cummings OW, Loehrer EJ: Tyrosin kinase receptor expression in thymomas. J Cancer Res Clin Oncol. 2004, 130: 222-224.","journal-title":"J Cancer Res Clin Oncol"},{"key":"996_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.cco.0000152628.43867.8e","volume":"17","author":"G Giaccone","year":"2005","unstructured":"Giaccone G: Treatment of malignant thymoma. Curr Opin Oncol. 2005, 17: 140-146.","journal-title":"Curr Opin Oncol"},{"key":"996_CR10","first-page":"805","volume":"35","author":"P Str\u00f6bel","year":"2004","unstructured":"Str\u00f6bel P, Marx A, Zettl A, Muller-Hermelink HK: Thymoma and thymic carcinoma: an update of the WHO classification 2004. Surg. 2004, 35: 805-811.","journal-title":"Surg"},{"key":"996_CR11","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/ijc.22078","volume":"119","author":"RJ Rieker","year":"2006","unstructured":"Rieker RJ, Joos S, Mechtersheimer G, Blaeker H, Schnabel PA, Morresi-Hauf A, Hecker E, Thomas M, Dienemann H, Schirmacher P, Kern MA: COX-2 upregulation in thymomas and thymic carcinomas. Int J Cancer. 2006, 119: 2063-2070.","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"996_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1746-1596-2-S1-S3","volume":"2","author":"RJ Rieker","year":"2007","unstructured":"Rieker RJ, Schnabel PA, Mechtersheimer G, Thomas M, Dienemann H, Schirmacher P, Kern MA: COX-2 expression in thymomas and thymic carcinomas: a novel therapeutic target?. Diagn Pathol. 2007, 2 (Suppl 1): S3-","journal-title":"Diagn Pathol"},{"key":"996_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1746-1596-7-120","volume":"7","author":"Y Ma","year":"2012","unstructured":"Ma Y, Li Q, Cui W, Miao N, Liu X, Zhang W, Zhang C, Wang J: Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems. Diagn Pathol. 2012, 7: 120-","journal-title":"Diagn Pathol"},{"key":"996_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/path.1514","volume":"20","author":"CC Pan","year":"2004","unstructured":"Pan CC, Chen PC, Chiang H: KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol. 2004, 20: 375-381.","journal-title":"J Pathol"},{"key":"996_CR15","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","volume":"350","author":"P Str\u00f6bel","year":"2004","unstructured":"Str\u00f6bel P, Hartmann M, Jakob A, Mikesch K, Brink I, Dirnhofer S, Marx A: Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med. 2004, 350: 2625-2626.","journal-title":"N Engl J Med"},{"key":"996_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1200\/JCO.2011.36.6427","volume":"29","author":"S Buti","year":"2011","unstructured":"Buti S, Donini M, Sergio P, Garagnani L, Schirosi L, Passalacqua R, Rossi G: Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma. J Clin Oncol. 2011, 29: 803-805.","journal-title":"J Clin Oncol"},{"key":"996_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/JTO.0b013e3181f209b9","volume":"5","author":"N Girard","year":"2010","unstructured":"Girard N: Thymic tumors: relevant molecular data in the clinic. J Thorac Oncol. 2010, 5: 291-295.","journal-title":"J Thorac Oncol"},{"key":"996_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb01181.x","volume":"23","author":"E Pescarmona","year":"1993","unstructured":"Pescarmona E, Pisacane A, Pignatelli E, Baroni CD: Expression of epidermal and nerve growth factor receptors in human thymus and thymomas. Histopathology. 1993, 23: 39-44.","journal-title":"Histopathology"},{"key":"996_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/jcp.48.5.447","volume":"48","author":"NE Gilhus","year":"1995","unstructured":"Gilhus NE, Jones M, Turley H, Gatter KC, Nagvekar N, Newsom-Davis J, Willcox N: Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen. J Clin Pathol. 1995, 48: 447-455.","journal-title":"J Clin Pathol"},{"key":"996_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","volume":"128","author":"JD Henley","year":"2002","unstructured":"Henley JD, Koukoulis GK, Loehrer PJ: Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol. 2002, 128: 167-170.","journal-title":"J Cancer Res Clin Oncol"},{"key":"996_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/jjco\/hyl028","volume":"36","author":"E Suzuki","year":"2006","unstructured":"Suzuki E, Sasaki H, Kawano O, Endo K, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y: Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors. Jpn J Clin Oncol. 2006, 36: 351-356.","journal-title":"Jpn J Clin Oncol"},{"key":"996_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","volume":"248","author":"M Meister","year":"2007","unstructured":"Meister M, Schirmacher P, Dienemann H, Mechtersheimer G, Schnabel PA, Kern MA, Herpel E, Xu EC, Muley T, Thomas M, Rieker RJ: Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Lett. 2007, 248: 186-191.","journal-title":"Cancer Lett"},{"key":"996_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","volume":"62","author":"K Yoh","year":"2008","unstructured":"Yoh K, Nishiwaki Y, Ishii G, Goto K, Kubota K, Ohmatsu H, Niho S, Nagai K, Saijo N: Mutational status of EGFR and KIT in thymoma and thymic carcinoma. Lung Cancer. 2008, 62: 316-320.","journal-title":"Lung Cancer"},{"key":"996_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/JTO.0b013e3181d86a30","volume":"5","author":"SC Aisner","year":"2010","unstructured":"Aisner SC, Dahlberg S, Hameed MR, Ettinger DS, Schiller JH, Johnson DH, Aisner J, Loehrer PJ: Epidermal growth factor receptor, C-Kit, and Her2\/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group Study. J Thorac Oncol. 2010, 5: 885-892.","journal-title":"J Thorac Oncol"},{"key":"996_CR25","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","volume":"15","author":"N Girard","year":"2009","unstructured":"Girard N, Shen R, Guo T, Zakowski MF, Heguy A, Riely GJ, Huang J, Lau C, Lash AE, Ladanyi M, Viale A, Antonescu CR, Travis WD, Rusch VW, Kris MG, Pao W: Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res. 2009, 15: 6790-6799.","journal-title":"Clin Cancer Res"},{"key":"996_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.lungcan.2006.01.009","volume":"52","author":"H Yamaguchi","year":"2006","unstructured":"Yamaguchi H, Soda H, Kitazaki T, Tsukamoto K, Hayashi T, Kohno S: Thymic carcinoma with epidermal growth factor receptor gene mutations. Lung Cancer. 2006, 52: 261-262.","journal-title":"Lung Cancer"},{"key":"996_CR27","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1200\/JCO.2005.09.985","volume":"23","author":"PA Janne","year":"2005","unstructured":"Janne PA, Engelman JA, Johnson BE: Epidermal growth factor receptor mutations in nonsmall-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol. 2005, 23: 3227-3234.","journal-title":"J Clin Oncol"},{"key":"996_CR28","doi-asserted-by":"crossref","first-page":"s7068","DOI":"10.1200\/jco.2005.23.16_suppl.7068","volume":"23","author":"A Kurup","year":"2005","unstructured":"Kurup A, Burns M, Dropcho S, Pao W, Loehrer PJ: Phase II study of gefitinib treatment in advanced thymic malignancies [abstract]. J Clin Oncol. 2005, 23: s7068-","journal-title":"J Clin Oncol"},{"key":"996_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa021633","volume":"348","author":"RS Sandler","year":"2003","unstructured":"Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003, 348: 883-890.","journal-title":"N Engl J Med"},{"key":"996_CR30","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1200\/JCO.2005.01.4332","volume":"23","author":"D Malka","year":"2005","unstructured":"Malka D, Pacault V, De Baere T, Ducreux M, Boige V: Antitumoral effect of celecoxib in hepatocellular carcinoma. J Clin Oncol. 2005, 23: 4805-4806.","journal-title":"J Clin Oncol"},{"key":"996_CR31","first-page":"429","volume":"7","author":"S Kulkarni","year":"2001","unstructured":"Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ: Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res. 2001, 7: 429-434.","journal-title":"Clin Cancer Res"},{"key":"996_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nm0302-289","volume":"8","author":"R Pai","year":"2002","unstructured":"Pai R, Soreghan B, Szabo IL, Pavelka MP, Baater D, Tarnawski AS: Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002, 8: 289-293.","journal-title":"Nat Med"},{"key":"996_CR33","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1096\/fj.02-1011com","volume":"17","author":"R Pai","year":"2003","unstructured":"Pai R, NakamuraT MWS, Tarnawski AS: Prostaglandins promote colon cancer invasion; signalling by cross-talk between two distinct growth factor receptors. FASEB J. 2003, 17: 1640-1647.","journal-title":"FASEB J"},{"key":"996_CR34","doi-asserted-by":"publisher","first-page":"9691","DOI":"10.1074\/jbc.M211360200","volume":"278","author":"YH Huh","year":"2003","unstructured":"Huh YH, Kim SH, Kim SJ, Chun JS: Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogen-activated protein kinase in articular. J Biol Chem. 2003, 278: 9691-9697.","journal-title":"J Biol Chem"},{"key":"996_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","volume":"103","author":"P Str\u00f6bel","year":"2010","unstructured":"Str\u00f6bel P, Bargou R, Wolff A, Spitzer D, Manegold C, Dimitrakopoulou-Strauss A, Strauss L, Sauer C, Mayer F, Hohenberger P, Marx A: Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer. 2010, 103: 196-200.","journal-title":"Br J Cancer"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-9-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:31:33Z","timestamp":1548117093000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-9-116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-9-116","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,16]]},"assertion":[{"value":"3 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"116"}}